With the opening of nearly 200 new drive-thru testing sites, the company brings its total testing sites to about 1,400, and its testing capacity will stand at more than 1.5 million tests per year. The company said it is working with local organizations to open eight rapid-response testing sites.
The expansion of the testing program aims to address the country’s need for testing and increase access in historically vulnerable communities. About 60 percent of CVS testing sites are accessible to communities facing social disparities that make them more susceptible to COVID-19, according to the CDC’s vulnerability index.
This growth in number of sites builds on the nearly 1,000 CVS opened in May.
More articles on pharmacy:
Sanofi expedites its vaccine timeline, strikes $2.3B deal with Translate Bio
FDA urged to increase safety warnings on common diabetes drug
Gilead to sign $275M deal with cancer drugmaker
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
